Bank of Kentucky’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$1.68M Buy
26,068
+307
+1% +$19.2K 0.39% 48
2014
Q4
$1.52M Hold
25,761
0.33% 52
2014
Q3
$1.32M Sell
25,761
-50
-0.2% -$2.5K 0.29% 53
2014
Q2
$1.25M Buy
25,811
+250
+1% +$12.3K 0.28% 51
2014
Q1
$1.33M Sell
25,561
-9,676
-27% -$515K 0.3% 47
2013
Q4
$1.87M Sell
35,237
-415
-1% -$21.1K 0.49% 44
2013
Q3
$1.65M Buy
35,652
+3,373
+10% +$148K 0.47% 45
2013
Q2
$1.44M Buy
+32,279
New +$1.4M 0.44% 44

Other funds holding BMY

Bank of Kentucky's BMY Position: Q1 2015 in Review

Bank of Kentucky increased its Bristol-Myers Squibb (BMY) stake by 1.2% in Q1 2015, buying an estimated $19.2K and bringing the position to 26,068 shares worth $1.68M. The position accounts for 0.39% of the portfolio, ranked #48.

Bank of Kentucky first reported a position in BMY in Q2 2013 and has held it in 8 quarters since. The position peaked at $1.87M in Q4 2013. 1,450 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

  • Bank of Kentucky held 26,068 shares of Bristol-Myers Squibb worth $1.68M as of Q1 2015.
  • Bank of Kentucky bought 307 Bristol-Myers Squibb shares in Q1 2015, an estimated $19.2K.
  • Bristol-Myers Squibb made up 0.39% of Bank of Kentucky's portfolio in Q1 2015, its #48 holding.
  • Bank of Kentucky first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 8 quarters since.
  • Bank of Kentucky's Bristol-Myers Squibb position peaked at $1.87M in Q4 2013.
  • 1,450 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Bank of Kentucky's 13F filing for Q1 2015, filed 28 Apr 2015.